H_GUCY2C CHO-K1 Cell Line
Cat. No.
GM-C19042
Size
Quote
Specifications
Data display
Materials
Cell Culture
Related products
Sequence
Specifications
Cat. NoGM-C19042
ProductH_GUCY2C CHO-K1 Cell Line
DescriptionH_GUCY2C CHO-K1 Cell Line is a clonal stable CHO-K1 cell line that constitutively expresses the human GUCY2C gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_GUCY2C
Gene ID/Uniprot IDP25092
Host CellCHO-K1
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Data display
H_GUCY2C CHO-K1 Cell Line (Cat. GM-C19042) was determined by flow cytometry using Anti-H_GUCY2C hIgG1 Antibody(Indusatumab) (Cat. GM-28860AB).(BECKMAN COULTER/CytoFLEX)
The passage stability of the H_GUCY2C CHO-K1 Cell Line (Cat. GM-C19042) was determined by flow cytometry using Anti-H_GUCY2C hIgG1 Antibody(Indusatumab) (Cat. GM-28860AB).(BECKMAN COULTER/CytoFLEX)
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum Cegrogen biotech/A0500-3010
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_GUCY2C hIgG1 Antibody Genomeditech/GM-28860AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Related products
CLDN18
Cynomolgus_CLDN18.2-eGFP CHO-K1 Cell Line H_CLDN18(isoform2)-eGFP 293 Cell Line H_CLDN18.1-eGFP HEK-293 Cell Line
H_CLDN18.2 MC38 Cell Line H_CLDN18.2 MKN45 Cell Line H_CLDN18.2 MKN45 Cell Line(High Expression)
H_CLDN18.2 MKN45 Cell Line(Low Expression) H_CLDN18.2 MKN45 Cell Line(Medium Expression) H_CLDN18.2(isoform2) CHO-K1 Cell Line
H_CLDN18.2-eGFP CT-26 Cell Line Mouse_CLDN18.2-eGFP CHO-K1 Cell Line Rat_CLDN18.2-eGFP CHO-K1 Cell Line
Rhesus_CLDN18.2-eGFP CHO-K1 Cell Line    
Anti-CLDN18.2  hIgG1 Reference Antibody  Anti-CLDN18.2 hIgG1 Antibody Anti-CLDN18.2 hIgG1 Antibody
HER3(ERBB3)
Cynomolgus_ERBB3(HER3) CHO-K1 Cell Line Cynomolgus_ERBB3(HER3) HEK-293 Cell Line H_ERBB3(HER3) CHO-K1 Cell Line
H_ERBB3(HER3) HEK-293 Cell Line H_ERBB3(HER3) MC38 Cell Line Mouse_HER3(ERBB3) CHO-K1 Cell Line
Anti-ERBB3(HER3) hIgG1 Reference Antibody Anti-H_ERBB3(HER3) hIgG1 Antibody  
Biotinylated Human HER3 Protein; His-Avi Tag Human HER3 Protein; His Tag Mouse HER3 Protein; His Tag
TROP2(TACSTD2)
Cynomolgus_Trop2 CHO-K1 Cell Line Cynomolgus_TROP2 HEK-293 Cell Line H_TROP2 CHO-K1 Cell Line
H_TROP2 CT26 Cell Line H_TROP2 HEK-293 Cell Line H_TROP2 LLC1 Cell Line
H_TROP2 MC38 Cell Line    
Anti-H_TROP2 hIgG1 Antibody Anti-TROP2 hIgG1 Antibody Anti-Trop2 hIgG1 Reference Antibody 
Anti-Trop2 hIgG1 Reference Antibody    
Anti-Trop2-DXD ADC(Dar4)[Datopotamab deruxtecan,Dato-DXD] Anti-Trop2-SN38 ADC(Dar8)[Sacituzumab govitecan]  
Human TROP2 Protein; His Tag    
GUCY2C(GC-C)
Cynomolgus_GUCY2C HEK-293 Cell Line H_GUCY2C HEK-293 Cell Line  
Anti-H_GUCY2C hIgG1 Antibody    
ADC Related Product
Anti-DXD Mouse IgG1 Antibody  Anti-DXD Mouse IgG1 Antibody  Anti-Dxd Mouse IgG2a Antibody 
Anti-Eribulin Mouse IgG2a Antibody Anti-MMAE Mouse IgG1 Antibody  Anti-MMAE Mouse IgG2a Antibody 
Anti-MMAE Mouse IgG2a Antibody  Mouse anti Human IgG-MMAE(Dar4)  
Human IgG1 Isotype-DXD (Dar8) Human IgG1 Isotype-Eribulin (Dar4) Human IgG1 Isotype-MMAE (Dar4)
Recombinant DT3C Protein    
Sequence

GUCY2C P25092
MKTLLLDLALWSLLFQPGWLSFSSQVSQNCHNGSYEISVLMMGNSAFAEPLKNLEDAVNEGLEIVRGRLQNAGLNVTVNATFMYSDGLIHNSGDCRSSTCEGLDLLRKISNAQRMGCVLIGPSCTYSTFQMYLDTELSYPMISAGSFGLSCDYKETLTRLMSPARKLMYFLVNFWKTNDLPFKTYSWSTSYVYKNGTETEDCFWYLNALEASVSYFSHELGFKVVLRQDKEFQDILMDHNRKSNVIIMCGGPEFLYKLKGDRAVAEDIVIILVDLFNDQYFEDNVTAPDYMKNVLVLTLSPGNSLLNSSFSRNLSPTKRDFALAYLNGILLFGHMLKIFLENGENITTPKFAHAFRNLTFEGYDGPVTLDDWGDVDSTMVLLYTSVDTKKYKVLLTYDTHVNKTYPVDMSPTFTWKNSKLPNDITGRGPQILMIAVFTLTGAVVLLLLVALLMLRKYRKDYELRQKKWSHIPPENIFPLETNETNHVSLKIDDDKRRDTIQRLRQCKYDKKRVILKDLKHNDGNFTEKQKIELNKLLQIDYYNLTKFYGTVKLDTMIFGVIEYCERGSLREVLNDTISYPDGTFMDWEFKISVLYDIAKGMSYLHSSKTEVHGRLKSTNCVVDSRMVVKITDFGCNSILPPKKDLWTAPEHLRQANISQKGDVYSYGIIAQEIILRKETFYTLSCRDRNEKIFRVENSNGMKPFRPDLFLETAEEKELEVYLLVKNCWEEDPEKRPDFKKIETTLAKIFGLFHDQKNESYMDTLIRRLQLYSRNLEHLVEERTQLYKAERDRADRLNFMLLPRLVVKSLKEKGFVEPELYEEVTIYFSDIVGFTTICKYSTPMEVVDMLNDIYKSFDHIVDHHDVYKVETIGDAYMVASGLPKRNGNRHAIDIAKMALEILSFMGTFELEHLPGLPIWIRIGVHSGPCAAGVVGIKMPRYCLFGDTVNTASRMESTGLPLRIHVSGSTIAILKRTECQFLYEVRGETYLKGRGNETTYWLTGMKDQKFNLPTPPTVENQQRLQAEFSDMIANSLQKRQAAGIRSQKPRRVASYKKGTLEYLQLNTTDKESTYF

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_GUCY2C CHO-K1 Cell Line
Cat. No.
GM-C19042
Size
Quote
Specifications
Data display
Materials
Cell Culture
Related products
Sequence
Specifications
Cat. NoGM-C19042
ProductH_GUCY2C CHO-K1 Cell Line
DescriptionH_GUCY2C CHO-K1 Cell Line is a clonal stable CHO-K1 cell line that constitutively expresses the human GUCY2C gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_GUCY2C
Gene ID/Uniprot IDP25092
Host CellCHO-K1
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Cat. NoGM-C19042
ProductH_GUCY2C CHO-K1 Cell Line
DescriptionH_GUCY2C CHO-K1 Cell Line is a clonal stable CHO-K1 cell line that constitutively expresses the human GUCY2C gene, constructed using lentiviral technology.
Product Format1 vial of frozen cells
Quantity3E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
TargetHuman_GUCY2C
Gene ID/Uniprot IDP25092
Host CellCHO-K1
Recovery MediumF12K+10% FBS+1% P.S
Growth mediumF12K+10% FBS+1% P.S+4 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Data display
H_GUCY2C CHO-K1 Cell Line (Cat. GM-C19042) was determined by flow cytometry using Anti-H_GUCY2C hIgG1 Antibody(Indusatumab) (Cat. GM-28860AB).(BECKMAN COULTER/CytoFLEX)
The passage stability of the H_GUCY2C CHO-K1 Cell Line (Cat. GM-C19042) was determined by flow cytometry using Anti-H_GUCY2C hIgG1 Antibody(Indusatumab) (Cat. GM-28860AB).(BECKMAN COULTER/CytoFLEX)
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum Cegrogen biotech/A0500-3010
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_GUCY2C hIgG1 Antibody Genomeditech/GM-28860AB
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum Cegrogen biotech/A0500-3010
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_GUCY2C hIgG1 Antibody Genomeditech/GM-28860AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Related products
CLDN18
Cynomolgus_CLDN18.2-eGFP CHO-K1 Cell Line H_CLDN18(isoform2)-eGFP 293 Cell Line H_CLDN18.1-eGFP HEK-293 Cell Line
H_CLDN18.2 MC38 Cell Line H_CLDN18.2 MKN45 Cell Line H_CLDN18.2 MKN45 Cell Line(High Expression)
H_CLDN18.2 MKN45 Cell Line(Low Expression) H_CLDN18.2 MKN45 Cell Line(Medium Expression) H_CLDN18.2(isoform2) CHO-K1 Cell Line
H_CLDN18.2-eGFP CT-26 Cell Line Mouse_CLDN18.2-eGFP CHO-K1 Cell Line Rat_CLDN18.2-eGFP CHO-K1 Cell Line
Rhesus_CLDN18.2-eGFP CHO-K1 Cell Line    
Anti-CLDN18.2  hIgG1 Reference Antibody  Anti-CLDN18.2 hIgG1 Antibody Anti-CLDN18.2 hIgG1 Antibody
HER3(ERBB3)
Cynomolgus_ERBB3(HER3) CHO-K1 Cell Line Cynomolgus_ERBB3(HER3) HEK-293 Cell Line H_ERBB3(HER3) CHO-K1 Cell Line
H_ERBB3(HER3) HEK-293 Cell Line H_ERBB3(HER3) MC38 Cell Line Mouse_HER3(ERBB3) CHO-K1 Cell Line
Anti-ERBB3(HER3) hIgG1 Reference Antibody Anti-H_ERBB3(HER3) hIgG1 Antibody  
Biotinylated Human HER3 Protein; His-Avi Tag Human HER3 Protein; His Tag Mouse HER3 Protein; His Tag
TROP2(TACSTD2)
Cynomolgus_Trop2 CHO-K1 Cell Line Cynomolgus_TROP2 HEK-293 Cell Line H_TROP2 CHO-K1 Cell Line
H_TROP2 CT26 Cell Line H_TROP2 HEK-293 Cell Line H_TROP2 LLC1 Cell Line
H_TROP2 MC38 Cell Line    
Anti-H_TROP2 hIgG1 Antibody Anti-TROP2 hIgG1 Antibody Anti-Trop2 hIgG1 Reference Antibody 
Anti-Trop2 hIgG1 Reference Antibody    
Anti-Trop2-DXD ADC(Dar4)[Datopotamab deruxtecan,Dato-DXD] Anti-Trop2-SN38 ADC(Dar8)[Sacituzumab govitecan]  
Human TROP2 Protein; His Tag    
GUCY2C(GC-C)
Cynomolgus_GUCY2C HEK-293 Cell Line H_GUCY2C HEK-293 Cell Line  
Anti-H_GUCY2C hIgG1 Antibody    
ADC Related Product
Anti-DXD Mouse IgG1 Antibody  Anti-DXD Mouse IgG1 Antibody  Anti-Dxd Mouse IgG2a Antibody 
Anti-Eribulin Mouse IgG2a Antibody Anti-MMAE Mouse IgG1 Antibody  Anti-MMAE Mouse IgG2a Antibody 
Anti-MMAE Mouse IgG2a Antibody  Mouse anti Human IgG-MMAE(Dar4)  
Human IgG1 Isotype-DXD (Dar8) Human IgG1 Isotype-Eribulin (Dar4) Human IgG1 Isotype-MMAE (Dar4)
Recombinant DT3C Protein    
Sequence

GUCY2C P25092
MKTLLLDLALWSLLFQPGWLSFSSQVSQNCHNGSYEISVLMMGNSAFAEPLKNLEDAVNEGLEIVRGRLQNAGLNVTVNATFMYSDGLIHNSGDCRSSTCEGLDLLRKISNAQRMGCVLIGPSCTYSTFQMYLDTELSYPMISAGSFGLSCDYKETLTRLMSPARKLMYFLVNFWKTNDLPFKTYSWSTSYVYKNGTETEDCFWYLNALEASVSYFSHELGFKVVLRQDKEFQDILMDHNRKSNVIIMCGGPEFLYKLKGDRAVAEDIVIILVDLFNDQYFEDNVTAPDYMKNVLVLTLSPGNSLLNSSFSRNLSPTKRDFALAYLNGILLFGHMLKIFLENGENITTPKFAHAFRNLTFEGYDGPVTLDDWGDVDSTMVLLYTSVDTKKYKVLLTYDTHVNKTYPVDMSPTFTWKNSKLPNDITGRGPQILMIAVFTLTGAVVLLLLVALLMLRKYRKDYELRQKKWSHIPPENIFPLETNETNHVSLKIDDDKRRDTIQRLRQCKYDKKRVILKDLKHNDGNFTEKQKIELNKLLQIDYYNLTKFYGTVKLDTMIFGVIEYCERGSLREVLNDTISYPDGTFMDWEFKISVLYDIAKGMSYLHSSKTEVHGRLKSTNCVVDSRMVVKITDFGCNSILPPKKDLWTAPEHLRQANISQKGDVYSYGIIAQEIILRKETFYTLSCRDRNEKIFRVENSNGMKPFRPDLFLETAEEKELEVYLLVKNCWEEDPEKRPDFKKIETTLAKIFGLFHDQKNESYMDTLIRRLQLYSRNLEHLVEERTQLYKAERDRADRLNFMLLPRLVVKSLKEKGFVEPELYEEVTIYFSDIVGFTTICKYSTPMEVVDMLNDIYKSFDHIVDHHDVYKVETIGDAYMVASGLPKRNGNRHAIDIAKMALEILSFMGTFELEHLPGLPIWIRIGVHSGPCAAGVVGIKMPRYCLFGDTVNTASRMESTGLPLRIHVSGSTIAILKRTECQFLYEVRGETYLKGRGNETTYWLTGMKDQKFNLPTPPTVENQQRLQAEFSDMIANSLQKRQAAGIRSQKPRRVASYKKGTLEYLQLNTTDKESTYF

GUCY2C P25092
MKTLLLDLALWSLLFQPGWLSFSSQVSQNCHNGSYEISVLMMGNSAFAEPLKNLEDAVNEGLEIVRGRLQNAGLNVTVNATFMYSDGLIHNSGDCRSSTCEGLDLLRKISNAQRMGCVLIGPSCTYSTFQMYLDTELSYPMISAGSFGLSCDYKETLTRLMSPARKLMYFLVNFWKTNDLPFKTYSWSTSYVYKNGTETEDCFWYLNALEASVSYFSHELGFKVVLRQDKEFQDILMDHNRKSNVIIMCGGPEFLYKLKGDRAVAEDIVIILVDLFNDQYFEDNVTAPDYMKNVLVLTLSPGNSLLNSSFSRNLSPTKRDFALAYLNGILLFGHMLKIFLENGENITTPKFAHAFRNLTFEGYDGPVTLDDWGDVDSTMVLLYTSVDTKKYKVLLTYDTHVNKTYPVDMSPTFTWKNSKLPNDITGRGPQILMIAVFTLTGAVVLLLLVALLMLRKYRKDYELRQKKWSHIPPENIFPLETNETNHVSLKIDDDKRRDTIQRLRQCKYDKKRVILKDLKHNDGNFTEKQKIELNKLLQIDYYNLTKFYGTVKLDTMIFGVIEYCERGSLREVLNDTISYPDGTFMDWEFKISVLYDIAKGMSYLHSSKTEVHGRLKSTNCVVDSRMVVKITDFGCNSILPPKKDLWTAPEHLRQANISQKGDVYSYGIIAQEIILRKETFYTLSCRDRNEKIFRVENSNGMKPFRPDLFLETAEEKELEVYLLVKNCWEEDPEKRPDFKKIETTLAKIFGLFHDQKNESYMDTLIRRLQLYSRNLEHLVEERTQLYKAERDRADRLNFMLLPRLVVKSLKEKGFVEPELYEEVTIYFSDIVGFTTICKYSTPMEVVDMLNDIYKSFDHIVDHHDVYKVETIGDAYMVASGLPKRNGNRHAIDIAKMALEILSFMGTFELEHLPGLPIWIRIGVHSGPCAAGVVGIKMPRYCLFGDTVNTASRMESTGLPLRIHVSGSTIAILKRTECQFLYEVRGETYLKGRGNETTYWLTGMKDQKFNLPTPPTVENQQRLQAEFSDMIANSLQKRQAAGIRSQKPRRVASYKKGTLEYLQLNTTDKESTYF

Message consultation
reset
submit
Message
Message consultation
reset
submit